Variant report

Variant	nsv466526
Chromosome Location	chr9:116901926-116924781
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:116916117-116916350	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:116917556-116917812	HepG2	liver:	n/a	n/a
3	ARID3A	chr9:116904220-116904556	HepG2	liver:	n/a	n/a
4	BACH1	chr9:116916262-116917825	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr9:116919190-116919252	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr9:116918832-116918950	H1-hESC	embryonic stem cell:	n/a	n/a
7	BHLHE40	chr9:116916072-116916459	HepG2	liver:	n/a	chr9:116916326-116916342
8	BHLHE40	chr9:116916169-116916429	HepG2	liver:	n/a	chr9:116916326-116916342
9	BHLHE40	chr9:116916046-116916890	HepG2	liver:	n/a	chr9:116916562-116916578 chr9:116916504-116916520 chr9:116916326-116916342
10	BHLHE40	chr9:116917582-116917706	K562	blood:	n/a	n/a
11	BHLHE40	chr9:116917652-116917813	GM12878	blood:	n/a	n/a
12	BRCA1	chr9:116917608-116917881	Hela-S3	cervix:	n/a	n/a
13	BRCA1	chr9:116916125-116916314	HepG2	liver:	n/a	n/a
14	CCNT2	chr9:116917603-116917846	K562	blood:	n/a	n/a
15	CEBPB	chr9:116917574-116917748	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr9:116920204-116920447	IMR90	lung:	n/a	n/a
17	CEBPB	chr9:116918582-116919517	IMR90	lung:	n/a	n/a
18	CEBPB	chr9:116918614-116918817	HepG2	liver:	n/a	n/a
19	CEBPB	chr9:116917541-116917736	HepG2	liver:	n/a	n/a
20	CEBPD	chr9:116916078-116916534	HepG2	liver:	n/a	n/a
21	CHD1	chr9:116917619-116917971	H1-hESC	embryonic stem cell:	n/a	n/a
22	CHD1	chr9:116917409-116920757	IMR90	lung:	n/a	n/a
23	CHD2	chr9:116917641-116917827	H1-hESC	embryonic stem cell:	n/a	n/a
24	CHD2	chr9:116917730-116917764	GM12878	blood:	n/a	n/a
25	CHD2	chr9:116916895-116917095	HepG2	liver:	n/a	n/a
26	CHD2	chr9:116916123-116916384	HepG2	liver:	n/a	chr9:116916326-116916336
27	CHD2	chr9:116917633-116917951	Hela-S3	cervix:	n/a	n/a
28	CREB1	chr9:116917536-116918110	A549	lung:	n/a	n/a
29	CTBP2	chr9:116915982-116917075	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTBP2	chr9:116917548-116918440	H1-hESC	embryonic stem cell:	n/a	n/a
31	CTBP2	chr9:116918708-116919951	H1-hESC	embryonic stem cell:	n/a	n/a
32	CTCF	chr9:116917620-116917770	AoAF	blood vessel:	n/a	chr9:116917702-116917720 chr9:116917722-116917740 chr9:116917715-116917728 chr9:116917725-116917738 chr9:116917712-116917730 chr9:116917705-116917718
33	CTCF	chr9:116919820-116919970	AG04449	skin:	n/a	n/a
34	CTCF	chr9:116915952-116916387	H1-hESC	embryonic stem cell:	n/a	chr9:116916166-116916179 chr9:116916164-116916182
35	CTCF	chr9:116918740-116918890	AG04449	skin:	n/a	n/a
36	CTCF	chr9:116919080-116919230	BJ	skin:	n/a	n/a
37	CTCF	chr9:116916987-116917108	GM12892	blood:	n/a	n/a
38	CTCF	chr9:116919060-116919210	HAc	cerebellar:	n/a	n/a
39	CTCF	chr9:116917640-116917790	Caco-2	colon:	n/a	chr9:116917702-116917720 chr9:116917722-116917740 chr9:116917715-116917728 chr9:116917725-116917738 chr9:116917712-116917730 chr9:116917705-116917718
40	CTCF	chr9:116917600-116917750	GM12873	blood:	n/a	chr9:116917702-116917720 chr9:116917722-116917740 chr9:116917715-116917728 chr9:116917725-116917738 chr9:116917712-116917730 chr9:116917705-116917718
41	CTCF	chr9:116916120-116916270	HVMF	connective:	n/a	chr9:116916166-116916179 chr9:116916164-116916182
42	CTCF	chr9:116915770-116916642	A549	lung:	n/a	chr9:116916166-116916179 chr9:116916164-116916182
43	CTCF	chr9:116917565-116917848	Hela-S3	cervix:	n/a	chr9:116917702-116917720 chr9:116917722-116917740 chr9:116917715-116917728 chr9:116917725-116917738 chr9:116917712-116917730 chr9:116917705-116917718
44	CTCF	chr9:116919040-116919190	HCM	heart:	n/a	n/a
45	CTCF	chr9:116919100-116919250	BJ	skin:	n/a	n/a
46	CTCF	chr9:116917640-116917790	AG09309	skin:	n/a	chr9:116917702-116917720 chr9:116917722-116917740 chr9:116917715-116917728 chr9:116917725-116917738 chr9:116917712-116917730 chr9:116917705-116917718
47	CTCF	chr9:116918760-116918910	HUVEC	blood vessel:	n/a	n/a
48	CTCF	chr9:116919060-116919210	HEEpiC	esophagus:	n/a	n/a
49	CTCF	chr9:116917640-116917790	GM12878	blood:	n/a	chr9:116917702-116917720 chr9:116917722-116917740 chr9:116917715-116917728 chr9:116917725-116917738 chr9:116917712-116917730 chr9:116917705-116917718
50	CTCF	chr9:116916100-116916250	HPAF	blood vessel:	n/a	chr9:116916166-116916179 chr9:116916164-116916182

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:116916031-116916081	Caco-2	colon:	n/a
2	chr9:116918183-116918233	Caco-2	colon:	n/a
3	chr9:116917393-116917443	HRPEpiC	eye:	n/a
4	chr9:116917393-116917443	HAEpiC	amniotic membrane:	n/a
5	chr9:116914074-116914124	MCF10A-Er-Src	breast:	n/a
6	chr9:116917393-116917443	HMEC	breast:	n/a
7	chr9:116918247-116918297	SKMC	muscle:	n/a
8	chr9:116914074-116914124	K562	blood:	n/a
9	chr9:116917393-116917443	HL-60	blood:	n/a
10	chr9:116918183-116918233	AoSMC	blood vessel:	n/a
11	chr9:116916031-116916081	NB4	blood:	n/a
12	chr9:116914074-116914124	HCM	heart:	n/a
13	chr9:116918247-116918297	H1-hESC	embryonic stem cell:	embryo
14	chr9:116914074-116914124	HRCEpiC	kidney:	n/a
15	chr9:116918183-116918233	HEEpiC	esophagus:	n/a
16	chr9:116918183-116918233	SK-N-MC	brain:	n/a
17	chr9:116914074-116914124	BJ	skin:	n/a
18	chr9:116918247-116918297	PrEC	prostate:	n/a
19	chr9:116917393-116917443	T-47D	breast:	n/a
20	chr9:116918247-116918297	AG09319	gingival:	n/a
21	chr9:116916031-116916081	HRPEpiC	eye:	n/a
22	chr9:116918477-116918527	AG09309	skin:	n/a
23	chr9:116918247-116918297	ProgFib	skin:	n/a
24	chr9:116918247-116918297	MCF10A-Er-Src	breast:	n/a
25	chr9:116918183-116918233	Hela-S3	cervix:	n/a
26	chr9:116918247-116918297	HUVEC	blood vessel:	n/a
27	chr9:116917393-116917443	AG04449	skin:	fetal
28	chr9:116918183-116918233	GM12891	blood:	n/a
29	chr9:116918247-116918297	A549	lung:	n/a
30	chr9:116918247-116918297	Jurkat	blood:	n/a
31	chr9:116917393-116917443	GM19239	blood:	n/a
32	chr9:116917393-116917443	HEK293	kidney:	embryo
33	chr9:116916031-116916081	NHBE	bronchial:	n/a
34	chr9:116914074-116914124	HNPCEpiC	eye:	n/a
35	chr9:116916031-116916081	BE2_C	brain:	n/a
36	chr9:116916031-116916081	HUVEC	blood vessel:	n/a
37	chr9:116918247-116918297	BE2_C	brain:	n/a
38	chr9:116917393-116917443	MCF10A-Er-Src	breast:	n/a
39	chr9:116916031-116916081	HAEpiC	amniotic membrane:	n/a
40	chr9:116918183-116918233	NB4	blood:	n/a
41	chr9:116918247-116918297	CMK	blood:	n/a
42	chr9:116914074-116914124	HEK293	kidney:	embryo
43	chr9:116918247-116918297	IMR90	lung:	fetal
44	chr9:116916031-116916081	IMR90	lung:	fetal
45	chr9:116917393-116917443	HIPEpiC	eye:	n/a
46	chr9:116918183-116918233	RPTEC	kidney:	n/a
47	chr9:116914074-116914124	GM12878	blood:	n/a
48	chr9:116916031-116916081	HCM	heart:	n/a
49	chr9:116917393-116917443	PrEC	prostate:	n/a
50	chr9:116918477-116918527	HMEC	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:116894422..116897805-chr9:116912339..116915406,3	MCF-7	breast:
2	chr9:116903323..116904967-chr9:116908753..116911536,2	K562	blood:
3	chr9:116846273..116847216-chr9:116922173..116922681,2	MCF-7	breast:
4	chr9:116915372..116918710-chr9:116920861..116924845,3	MCF-7	breast:
5	chr9:116906533..116909775-chr9:116912915..116915543,3	MCF-7	breast:
6	chr9:116909854..116913482-chr9:116913961..116916713,3	MCF-7	breast:
7	chr9:116901825..116904823-chr9:116906598..116910253,3	K562	blood:
8	chr9:116899310..116902540-chr9:116902912..116904896,4	K562	blood:
9	chr9:116909854..116913482-chr9:116913961..116916713,3	MCF-7	breast:
10	chr9:116918924..116921858-chr9:116922744..116925296,3	K562	blood:
11	chr9:116870237..116871907-chr9:116924776..116927376,2	MCF-7	breast:
12	chr9:116899310..116902540-chr9:116902912..116904896,4	K562	blood:
13	chr9:116869949..116870838-chr9:116915614..116916621,9	MCF-7	breast:
14	chr9:116922253..116925161-chr9:116948030..116950142,2	MCF-7	breast:
15	chr9:116903323..116904967-chr9:116908753..116911536,2	K562	blood:
16	chr9:116918924..116921858-chr9:116922744..116925296,3	K562	blood:
17	chr9:116918121..116920168-chr9:116937255..116940070,3	K562	blood:
18	chr9:116869891..116870803-chr9:116915238..116916605,3	MCF-7	breast:
19	chr9:116901825..116904823-chr9:116906598..116910253,3	K562	blood:
20	chr9:116917422..116918284-chr9:117067805..117069207,4	K562	blood:
21	chr9:116906533..116909775-chr9:116912915..116915543,3	MCF-7	breast:
22	chr9:116914824..116917398-chr9:116971543..116973662,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KIF12-2	chr9:116914873-116914992	NONHSAT134368
2	lnc-KIF12-3	chr9:116921639-116921808	NONHSAT134369
3	lnc-KIF12-2	chr9:116906868-116907335	NONHSAT134368
4	lnc-KIF12-2	chr9:116908781-116909341	NONHSAT134368

Variant related genes	Relation type
COL27A1	TF binding region
COL27A1	CpG island
ENSG00000196739	chromatin interactions
ENSG00000207726	chromatin interactions

Extended variants
information (count: 837 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:837 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1017360	chr9:116901926-116901927	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs577260309	chr9:116902026-116902027	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs542999404	chr9:116902028-116902029	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs557260693	chr9:116902052-116902053	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs545174151	chr9:116902059-116902060	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs542920556	chr9:116902062-116902063	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs74656195	chr9:116902069-116902070	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs528632944	chr9:116902134-116902135	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs530827429	chr9:116902158-116902159	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs545566734	chr9:116902159-116902160	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs79734440	chr9:116902177-116902178	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs530960586	chr9:116902215-116902216	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs141851971	chr9:116902240-116902241	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs377390579	chr9:116902274-116902275	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs373512241	chr9:116902284-116902285	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs567521711	chr9:116902299-116902300	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs116926759	chr9:116902367-116902368	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs370498572	chr9:116902420-116902421	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs548965641	chr9:116902430-116902431	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs565869579	chr9:116902445-116902446	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs191580377	chr9:116902514-116902515	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs111718880	chr9:116902517-116902518	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs570990103	chr9:116902598-116902599	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs181112299	chr9:116902683-116902684	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs536720973	chr9:116902684-116902685	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs4979340	chr9:116902687-116902688	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs72760649	chr9:116902691-116902692	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs538008460	chr9:116902697-116902698	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs546764761	chr9:116902706-116902707	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs186507788	chr9:116902779-116902780	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs7868176	chr9:116902782-116902783	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs118038422	chr9:116902812-116902813	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs575827740	chr9:116902825-116902826	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs191008203	chr9:116902846-116902847	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs78597052	chr9:116902936-116902937	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs376017333	chr9:116903017-116903018	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs148399276	chr9:116903080-116903081	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs529995570	chr9:116903096-116903097	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs7041864	chr9:116903097-116903098	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs2761685	chr9:116903101-116903102	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs114928902	chr9:116903147-116903148	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs550707038	chr9:116903236-116903237	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs142493348	chr9:116903239-116903240	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs182395291	chr9:116903251-116903252	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs571076079	chr9:116903252-116903253	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs536761588	chr9:116903273-116903274	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs550361194	chr9:116903287-116903288	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs567302942	chr9:116903327-116903328	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs536230185	chr9:116903341-116903342	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs150542234	chr9:116903369-116903370	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
small cell lung cancer	20016488	CNVD
Cardiac fibroma	18329553	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Lung cancer	19147751	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16272173	CNVD
Bladder cancer	21909424	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21509527	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Cervical cancer	16585170	CNVD
Ependymoma	19289631	CNVD
Melanoma	17363583	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:1012 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:116892800-116916000	Weak transcription	Gastric	stomach
2	chr9:116900000-116903200	Bivalent Enhancer	Placenta	Placenta
3	chr9:116900600-116902200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr9:116900600-116902200	Enhancers	Adipose Nuclei	Adipose
5	chr9:116900600-116903200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr9:116900600-116904600	Enhancers	Skeletal Muscle Female	skeletal muscle
7	chr9:116900800-116902000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
8	chr9:116900800-116902600	Bivalent Enhancer	Fetal Muscle Leg	muscle
9	chr9:116900800-116905000	Enhancers	Left Ventricle	heart
10	chr9:116900800-116905200	Enhancers	Skeletal Muscle Male	skeletal muscle
11	chr9:116900800-116906200	Enhancers	HepG2	liver
12	chr9:116901000-116902000	Enhancers	Spleen	Spleen
13	chr9:116901000-116902800	Weak transcription	Psoas Muscle	Psoas
14	chr9:116901000-116903000	Enhancers	Brain Substantia Nigra	brain
15	chr9:116901200-116903400	Weak transcription	Right Ventricle	heart
16	chr9:116901200-116905000	Enhancers	Fetal Lung	lung
17	chr9:116901400-116903000	Enhancers	Brain Anterior Caudate	brain
18	chr9:116901800-116902000	Enhancers	Fetal Muscle Trunk	muscle
19	chr9:116901800-116902600	Enhancers	Stomach Mucosa	stomach
20	chr9:116901800-116903000	Enhancers	Colon Smooth Muscle	Colon
21	chr9:116901800-116903200	Bivalent Enhancer	Brain Cingulate Gyrus	brain
22	chr9:116901800-116903200	Enhancers	Lung	lung
23	chr9:116901800-116903600	Enhancers	Cortex derived primary cultured neurospheres	brain
24	chr9:116901800-116904000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr9:116901800-116904400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
26	chr9:116901800-116904800	Enhancers	Fetal Heart	heart
27	chr9:116901800-116904800	Enhancers	Ovary	ovary
28	chr9:116901800-116905000	Enhancers	Right Atrium	heart
29	chr9:116902000-116902600	Enhancers	Brain Angular Gyrus	brain
30	chr9:116902000-116902600	Bivalent Enhancer	Brain Hippocampus Middle	brain
31	chr9:116902000-116903000	Weak transcription	Spleen	Spleen
32	chr9:116902000-116903400	Weak transcription	Fetal Muscle Trunk	muscle
33	chr9:116902200-116902400	Enhancers	Liver	Liver
34	chr9:116902200-116902800	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr9:116902200-116903800	Weak transcription	Adipose Nuclei	Adipose
36	chr9:116902200-116906000	Enhancers	Fetal Stomach	stomach
37	chr9:116902400-116903400	Weak transcription	Liver	Liver
38	chr9:116902400-116904200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
39	chr9:116902400-116905600	Enhancers	HSMMtube	muscle
40	chr9:116902600-116903800	Weak transcription	Stomach Mucosa	stomach
41	chr9:116902600-116904800	Enhancers	Duodenum Smooth Muscle	Duodenum
42	chr9:116902600-116907800	Enhancers	Fetal Muscle Leg	muscle
43	chr9:116902800-116903000	Bivalent Enhancer	HSMM	muscle
44	chr9:116902800-116903200	Enhancers	Stomach Smooth Muscle	stomach
45	chr9:116902800-116904800	Enhancers	Psoas Muscle	Psoas
46	chr9:116903000-116903200	Enhancers	Spleen	Spleen
47	chr9:116903000-116903400	Flanking Active TSS	Colon Smooth Muscle	Colon
48	chr9:116903000-116903800	Weak transcription	Brain Substantia Nigra	brain
49	chr9:116903000-116904600	Enhancers	Fetal Intestine Small	intestine
50	chr9:116903000-116904600	Enhancers	Rectal Smooth Muscle	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links